Zeltia Articles
The solution for Spanish pharma companies lies abroad
13 March 2013
Spain's Zeltia is turning a corner, say Edison analysts
28 February 2013
Zeltia's Yondelis approved for sale in 10 new countries
4 December 2012
UK’s NICE turns down PharmaMar’s Yondelis and GlaxoSmithKline’s Arzerra
20 September 2010
US FDA briefs: fast-track for Zeltia’s Zentylor; OK for Baxter’s Protopam; warning on gadolinium-based contrast agents
13 September 2010
Showing 1-9 of 9 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
